Biotechnology company
Active 2021–2026. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | JEFFREY J. KIMBELL & ASSOCIATES, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$10,000 | |
| 2026 | JEFFREY J. KIMBELL & ASSOCIATES, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$10,000 | |
| 2026 | JEFFREY J. KIMBELL & ASSOCIATES, INC. |
2nd Quarter (Apr 1 - June 30) Registration |
— | |
| 2025 | KING & SPALDING LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination (No Activity) |
— | |
| 2025 | KING & SPALDING LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
$30,000 | |
| 2024 | KING & SPALDING LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | |
| 2024 | KING & SPALDING LLP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$30,000 | |
| 2024 | KING & SPALDING LLP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | |
| 2024 | KING & SPALDING LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$30,000 | |
| 2023 | KING & SPALDING LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$60,000 |
| Firm | Filings | Amount |
|---|---|---|
| KING & SPALDING LLP | 19 | $850,000 |
| JEFFREY J. KIMBELL & ASSOCIATES, INC. | 3 | $20,000 |
| Issue | Activities |
|---|---|
| Health Issues | 20 |